Pulmonx Corporation LUNG Asia Pacific — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's asia pacific — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's asia pacific — revenue?
- Pulmonx Corporation (LUNG) reported asia pacific — revenue of $707K in Q1 2026.
- How has Pulmonx Corporation's asia pacific — revenue changed year-over-year?
- Pulmonx Corporation's asia pacific — revenue decreased by 74.7% year-over-year, from $2.8M to $707K.
- What is the long-term trend for Pulmonx Corporation's asia pacific — revenue?
- Over 4 years (2021 to 2025), Pulmonx Corporation's asia pacific — revenue has grown at a 16.2% compound annual growth rate (CAGR), from $3.41M to $6.23M.
- What does asia pacific — revenue mean?
- This metric represents the total gross sales generated from the sale of medical devices and diagnostic platforms within the Asia Pacific geographic region. It serves as a key indicator of the company's market penetration and adoption rates for its minimally invasive respiratory treatments in this specific territory. Growth in this figure reflects successful commercial expansion and increasing demand for the company's specialized pulmonary solutions in international markets.